Akums Drugs Outperforms Sector Amid Broader Market Surge and Short-Term Gains

Akums Drugs & Pharmaceuticals has shown significant activity today, with the stock rising by 6.63% as of May 15, 2025. This performance has allowed the company to outperform its sector by 5.56%. Over the past four days, Akums has consistently gained, accumulating a total return of 8.28% during this period. The stock reached an intraday high of Rs 548.85, reflecting a 6.1% increase at its peak.
In terms of moving averages, Akums Drugs is currently positioned above its 5-day, 20-day, 50-day, and 100-day moving averages, although it remains below its 200-day moving average.

In the broader market context, the Sensex experienced a sharp rise of 1.59%, climbing 1,270.99 points to reach 82,625.42. The index is now just 4.06% shy of its 52-week high. While Akums has shown strong short-term performance, its year-to-date results reflect a decline of 13.88%, contrasting with the Sensex's gain of 5.72% over the same period.